According to a new market report published by Lucintel, the future of the molecular diagnostics market looks promising with opportunities in the infectious disease, oncology, and genetic test applications. The global molecular diagnostics market is expected to grow with a CAGR of 8% from 2020 to 2025. The major drivers for this market are increasing prevalence of chronic and infectious diseases, rising awareness of personalized medicines and companion diagnostics, and the growing biomarker identification market.
To download report brochure, please go to https://www.lucintel.com/molecular-diagnostics-market.aspx and click "download brochure" tab from the menu
Molecular diagnostics is a technique used to identify and analyze biological markers in the genome and proteome at a molecular level. In this market, reagents & kits, instruments, and services & software are the major product and service segments. Lucintel forecasts that reagents and kits will remain the largest product and service segment over the forecast period due to increasing research activities related to cancer and rising commercial applications.
Within this market, infectious diseases will remain the largest segment by application over the forecast period due to increasing hospital acquired infections.
Asia Pacific is expected to witness the highest growth over the forecast period due to rising disposable income, development of advanced healthcare infrastructure, and increasing penetration of cutting-edge clinical laboratory technologies in the region.
Roche, Qiagen, Hologic, Abbott Laboratories, Grifols, Siemens Healthcare, B&D, Beckman Coulter, bioMérieux, and Danaher are among the major suppliers in the global molecular diagnostics market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global molecular diagnostics market by product and service, technology, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Molecular Diagnostics Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global molecular diagnostics market by product and service, technology, application, end user, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Reagents & Kits
Instruments
Services & Software
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
DNA (Deoxyribonucleic Acid) Sequencing & Next Generation Sequencing (NGS)
In Situ Hybridization
DNA Microarray
Other Technologies
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Infectious Diseases
Hepatitis
HIV (Human Immunodeficiency Virus)
CT/NG (Chlamydia Trachomatis)
HAIs (Hospital Acquired Infections)
HPV (Human Papillomavirus)
Tuberculosis
Influenza
Other Infectious Diseases
Oncology
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Other Cancers
Genetic Tests
Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals & Academic Laboratories
Reference Laboratories
Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.